Aurobindo Pharma shares tumble 9% after USFDA issues Form 483 for Hyderabad facility
Updated : November 14, 2019 10:13 AM IST
Shares of Aurobindo Pharma tumbled over 9 percent on Thursday after the US drug regulator issued a 'Form 483' to its Hyderabad facility with 14 observations.
The pharma company said that they believe that none of these observations are related to data integrity issues.
Earlier this week, the company also reported its September-quarter numbers.
Have you signed up for Primo, our daily newsletter?It has all the stories and data on the market, business, economy and tech that you need to know.
THANK YOU! You made our day. See you every morningYOUR EMAIL IS ON ITS WAY. Check your inbox for future updates.
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more